These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 230912)

  • 1. Studies on viomycin. XIV. Roles of basic and cyclic moieties in the antimicrobial activity of viomycin.
    Kitagawa T; Miura T; Kurose H
    Chem Pharm Bull (Tokyo); 1979 Nov; 27(11):2551-6. PubMed ID: 230912
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships between antimicrobial activities and chemically reactive functions in viomycin.
    Kitagawa T; Miura T; Tanaka S; Taniyama H
    J Antibiot (Tokyo); 1972 Jul; 25(7):429-31. PubMed ID: 4350197
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on viomycin. VIII. Selective modifications of the terminal amino groups of viomycin.
    Kitagawa T; Miura T; Takaishi M; Taniyama H
    Chem Pharm Bull (Tokyo); 1975 Sep; 23(9):2123-7. PubMed ID: 171092
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on viomycin IX. Amino acid derivatives on viomycin.
    Kitagawa T; Miura T; Takaishi C; Taniyama H
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
    [No Abstract]   [Full Text] [Related]  

  • 5. [Derivatives of viomycin. V. Di(oxytetracyclinemethyl)viomycin and tri(oxytetracyclinemethyl)viomycin, preparation and properties].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1969; 26(3):237-40. PubMed ID: 4308291
    [No Abstract]   [Full Text] [Related]  

  • 6. [Derivatives of viomycin. 3. Viomycin-methyltetracyclines, their preparation and properties].
    Sobiczewski W; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1968; 25(6):563-7. PubMed ID: 4307876
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular mechanism of viomycin inhibition of peptide elongation in bacteria.
    Holm M; Borg A; Ehrenberg M; Sanyal S
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):978-83. PubMed ID: 26755601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Viomycin derivatives. IV. Preparation and properties of some penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1969; 26(1):29-32. PubMed ID: 4305691
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationships between antimicrobial activities and chemical structures of reduced products of viomycin.
    Kitagawa T; Miura T; Tanaka S; Taniyama H
    J Antibiot (Tokyo); 1973 Sep; 26(9):528-31. PubMed ID: 4365319
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on viomycin. VII. Oxidative modifications of viomycin.
    Kitagawa T; Miura T; Sawada Y; Fujiwara K; Ito R
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1827-34. PubMed ID: 4371987
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of some viomycinmethyltetracyclines].
    Sobiczewski W; Cendrowska H; Chojnowski W
    Acta Pol Pharm; 1969; 26(6):505-10. PubMed ID: 4314647
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of viomycin, an anti-tuberculosis antibiotic: copper(ii) coordination, DNA degradation and the impact on delta ribozyme cleavage activity.
    Stokowa-Sołtys K; Barbosa NA; Kasprowicz A; Wieczorek R; Gaggelli N; Gaggelli E; Valensin G; Wrzesiński J; Ciesiołka J; Kuliński T; Szczepanik W; Jeżowska-Bojczuk M
    Dalton Trans; 2016 May; 45(20):8645-58. PubMed ID: 27143296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro sensitivity of various micro-organisms from animal sources to viomycin].
    DEOM J; MORTELMANS J
    Antonie Van Leeuwenhoek; 1955; 21(4):377-81. PubMed ID: 13327858
    [No Abstract]   [Full Text] [Related]  

  • 14. [Viomycin and associated viomycin with streptomycin in experimental tuberculosis resistant to streptomycin].
    MASI A; MOGGI P
    Riv Clin Pediatr; 1951 Dec; 49(12):853-64. PubMed ID: 14921667
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basic studies on viomycin and tuberactinomycin (author's transl)].
    Aoyagi T; Kawai T; Yamada Y; Fujino T; Kaneko K
    Kekkaku; 1975 Oct; 50(10):295-301. PubMed ID: 175205
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new tuberculosis antibiotic; viomycin].
    Resen Clin Cient; 1952 Oct; 21(10):350. PubMed ID: 13027645
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance to the antibiotics viomycin and capreomycin in the Streptomyces species which produce them.
    Skinner RH; Cundliffe E
    J Gen Microbiol; 1980 Sep; 120(1):95-104. PubMed ID: 6163840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of VioG and VioQ in the incorporation and modification of the Capreomycidine residue in the peptide antibiotic viomycin.
    Fei X; Yin X; Zhang L; Zabriskie TM
    J Nat Prod; 2007 Apr; 70(4):618-22. PubMed ID: 17302456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viomycin in experimental diphtheria infections].
    MASI A; DETTORI M
    Riv Clin Pediatr; 1952 Aug; 50(8):559-62. PubMed ID: 13004796
    [No Abstract]   [Full Text] [Related]  

  • 20. [Viomycin, a new tuberculostatic antibiotic].
    LEVADITI C; VAISMAN A; HENRY-EVENO J; CHAIGNEAU-ERHARD H
    Rev Immunol Ther Antimicrob; 1951; 15(5-6):298-320. PubMed ID: 14942194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.